Cancer Supportive Care Progams National and International Improving Quality of Life Logo
Fifth Dimension Table of Contents

 

Eye Cancer Therapy Toxicity Issues
Sabrina Selim, BA, Ernest H. Rosenbaum MD, Robert J. Ignoffo, PharmD, FASH, Jean Chan, BA, MA, SEd, Lee Schwartz, MD

graphic of the eye showing the lacrimal gland, lacrimal canaliculi, lacrimal puncta, conjunctiva and eyelid


5-FU (5-Fluorouracil)

Background
5FU is commonly used alone or in combination with other chemotherapy agents (CMF= cyclophosphomide, methotrexate and 5-FU) for breast, gastrointestinal (GI) and genitourinary cancer. It interferes with the division of tumor and other rapidly dividing cells by preventing proper DNA duplication. Although this generally leads to tumor cell death, it also affects organs with a rapid cell turnover including those of the GI tract, skin, bone marrow and the surface cells of the eye. One common effect is inflammation of the mucous membranes (mucositis) see Mucositis - Oral, Esophageal and Gastrointestinal Problems and Solutions in the mouth, GI tract and conjunctiva in the eye.

Common Ocular Side Effects
Since 5-FU interferes with cell division, it affects the normal renewal of tissue in the eye, especially the tear duct, cornea and conjunctiva. Ocular side-effects generally start gradually 1- 2 weeks after initiation of the first 5-FU cycle and resolve within 10-15 days after they appear. Toxicity to the surface of the eye almost always goes away 2-3 weeks after stopping infusions of 5-FU. They become apparant as either symptoms on the surface of the eye, or as problems with the nerves leading to the eye muscles (neuromotility) disorders. It should be noted that the incidence of ocular toxicity due to 5-FU is quite small. However, it is important to report any unusual symptoms to your doctor. The following are the most common side-effects of 5-FU:

These Symptoms were Reported in 25-39% of People Taking 5-FU Therapy

These Symptoms are Much Less Common

Tips for Symptom Prevention and Manangement :
Early detection and management of symptoms are very important to prevent blockage of the tear drainage system and tears spilling over. Although it is unrealistic to avoid chemotherapy on account of relatively minor eye effects, it is important to be aware that side-effects may occur. These are generally manageable with regular check-ups with an ophthalmologist.


Index CancerSupportiveCare.com  |  SiteIndex CancerSupportiveCare.com  |  Search CancerSupportiveCare  |  Contact Us  |  Books  |  Top
First appeared August 12, 2002; updated July 8, 2007